![](/img/cover-not-exists.png)
FOLFIRI with cetuximab or bevacizumab: FIRE-3
Petrelli, Fausto, Coinu, Andrea, Barni, SandroVolume:
15
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(14)70400-0
Date:
December, 2014
File:
PDF, 51 KB
english, 2014